Kim Soyoung, Lim Ancho, Kim Young-Eun, Lee Youngseop, Jun Hyeong Joon, Yim Mi Hong, Kim Daehyeok, Jun Purumea, Park Jeong Hwan, Lee Sanghun
KM Data Division, Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
Korean Convergence Medical Science, University of Science and Technology, Daejeon 34113, Republic of Korea.
Healthcare (Basel). 2024 Apr 29;12(9):918. doi: 10.3390/healthcare12090918.
We established a protocol for the traditional Korean medicine examination (KME) and methodically gathered data following this protocol. Potential indicators for KME were extracted through a literature review; the first KME protocol was developed based on three rounds of expert opinions. The first KME protocol's feasibility was confirmed, and data were collected over four years from traditional Korean medicine (KM) hospitals, focusing on healthy adults, using the final KME protocol. A literature review identified 175 potential core indicators, condensed into 73 indicators after three rounds of expert consultation. The first KME protocol, which was categorized under questionnaires and medical examinations, was developed after the third round of expert opinions. A pilot study using the first KME protocol was conducted to ensure its validity, leading to modifications resulting in the development of the final KME protocol. Over four years, data were collected from six KM hospitals, focusing on healthy adults; we obtained a dataset comprising 11,036 healthy adults. This is the first protocol incorporating core indicators of KME in a quantitative form and systematically collecting data. Our protocol holds potential merit in evaluating predisposition to diseases or predicting diseases.
我们制定了一份韩医学检查(KME)方案,并按照该方案有条不紊地收集数据。通过文献回顾提取了KME的潜在指标;基于三轮专家意见制定了首个KME方案。确认了首个KME方案的可行性,并使用最终的KME方案,在四年时间里从韩医医院收集数据,重点关注健康成年人。文献回顾确定了175个潜在核心指标,经过三轮专家咨询后浓缩为73个指标。首个KME方案分为问卷调查和医学检查两类,是在第三轮专家意见后制定的。使用首个KME方案进行了一项试点研究以确保其有效性,随后进行了修改,从而制定出最终的KME方案。在四年时间里,从六家韩医医院收集数据,重点关注健康成年人;我们获得了一个包含11036名健康成年人的数据集。这是首个以定量形式纳入KME核心指标并系统收集数据的方案。我们的方案在评估疾病易感性或预测疾病方面具有潜在价值。